Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function

Transplantation

Volumn 77, Issue 5, 2004, Pages 710-717

  Gleissner, Christian A ^a   Murat, Ammanouil ^a   Schäfer, Susanne ^b   Klingenberg, Roland ^a   Koch, Achim ^a   Remppis, Andrew ^a   Zimmermann, Rainer ^a   Katus, Hugo A ^a   Dengler, Thomas J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b IST GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; STEROID;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; KAPLAN MEIER METHOD; KIDNEY DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL TIME; THROMBOCYTE COUNT;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 1642387713     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000116443.64958.88     Document Type: Article

References (18)

1. Braunwald E, Fauci AS, Hauser SL, et al., eds. Harrison's principles of internal medicine [ed 15]. New York, McGraw-Hill Book Company 2001, pp. 1181.
2. Frost AE, Keller CA. Anemia and erythropoietin levels in recipients of solid organ transplants: The Multi-Organ Transplant Group. Transplantation 1993; 56: 1008.
3. Hunt BJ, Amin S, Halil O, et al. The prevalence, course, and characteristics of chronic anemia after heart and lung transplantation. Transplantation 1992; 53: 1251.
4. Müller HM, Horina JH, Kniepeiss D, et al. Characteristics and clinical relevance of chronic anemia in adult heart transplant recipients. Clin Transplant 2001; 15: 343.
5. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 17: 1230.
6. Al Falluji N, Lawrence-Nelson J, Kostis JB, et al. Effect of anemia on 1-year mortality in patients with acute myocardial infarction: Myocardial Infarction Data Acquisition System (MIDAS #8) Study Group. Am Heart J 2002; 144: 636.
7. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 11: 1780.
8. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 2001; 37: 1775.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
10. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587.
11. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223.
12. Kalra PR, Collier T, Cowie MR, et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet 2003; 263: 211.
13. Veillon S, Caillard S, Epailly E, et al. Chronic renal failure after cardiac transplantation: Predictive factors and influence on mortality-results of a monocenter study in 141 patients. Transplant Proc 2002; 34: 2819.
14. Abraham KA, McGorrian C, O'Kelly P, et al. The effect of pre-existing ischaemic heart transplant recipients. Am J Transplant 2002; 2: 355.
15. Beguin Y, Clemons GK, Pootrakul P, et al. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993; 4: 1067.
16. Portoles J, Torralbo A, Martin P, et al. Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 1997; 29: 541.
17. Hayashi T, Suzuki A, Shoji T, et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 2002; 35: 250.
18. Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiological stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340.